| XBIOTECH INC. |
| Kanada |
| Gesundheit |
| CA98400H1029 / A14QF1 |
| 4XB (Frankfurt) / XBIT (NASDAQ) |
| FRA:4XB, ETR:4XB, 4XB:GR, NASDAQ:XBIT |
| - |
| https://www.xbiotech.com/ |
|
XBiotech Inc. is a biotechnology company involved in the development, production, and commercialization of therapeutic antibodies designed to treat serious human diseases. This company focuses on its proprietary True Human™ antibodies, which are de..
>Volltext.. |
| 59.84 Mio. EUR |
| -46.11 Mio. EUR |
| - |
| -46.69 Mio. EUR |
| -39.38 Mio. EUR |
| -1.29 EUR |
| - |
| 108.56 Mio. EUR |
| -34.52 Mio. EUR |
| 15.83 |
| - |
| -4.17% |
| - |
| - |
| - |
| 15.07.21 - 2.119013€ |
| - |
| XBIOTECH |
| 01.04.26 |
|